Olivia Munn, an actress and advocate for breast cancer awareness, recently disclosed that her mother, Kim Munn, has been diagnosed with breast cancer after undergoing the same risk assessment test that Olivia credits with identifying her own cancer. Since her diagnosis in 2024 with Luminal B breast cancer, Olivia has been vocal about the importance of understanding genetic risk factors for the disease.
In a recent Instagram post, Olivia emphasized the significance of the Lifetime Risk Assessment test, highlighting its role in both her and her mother’s cancer journeys. Following her aggressive diagnosis, Olivia underwent a double mastectomy, hysterectomy, and bilateral salpingo-oophorectomy to reduce the risk of cancer recurrence.
Medical professionals underscore the importance of genetic testing, particularly for mutations like the BRCA gene, which are linked to increased breast cancer risk. According to Dr. Louise Morrell, a medical oncologist, while BRCA mutations occur in a small percentage of the population, they significantly contribute to familial breast cancer cases. She noted that about 5-10% of breast cancer cases involve individuals with a family history of the disease.
Dr. Morrell further explained that genetic tests can identify high-risk mutations, but most cancers cannot be solely attributed to family history. A negative genetic test does not eliminate the possibility of familial factors influencing cancer risk.
Olivia Munn’s situation exemplifies the critical role of genetic screening and awareness in breast cancer prevention and management, as well as its potential to save lives through early detection and intervention.